)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Rhoen Klinikum
Rhoen Klinikum (RHK) investor relations material
Rhoen Klinikum H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary6 Aug, 2026
Executive summary
Revenues increased by 3.6% year-over-year to €863.6 million, driven by moderate growth in inpatient and semi-inpatient treatments (+1.8%), a significant rise in outpatient cases (+11.0%) following the acquisition of Ortho Centrum Saale MVZ GmbH, and a 9% increase in patient numbers to 513,700 in H1 2026.
EBITDA rose by €10.3 million to €57.0 million, and consolidated profit increased by €7.8 million to €22.5 million, with a stable equity ratio of 74.4%.
Positive business development was supported by legislative measures offsetting personnel and material costs, despite ongoing geopolitical and regulatory challenges.
Ongoing investments in regional health networks and medical technology are underway.
Financial highlights
EBIT increased by €10.1 million (58.4%) to €27.4 million year-over-year.
EBT rose by €9.9 million (51.0%) to €29.3 million, and earnings per share improved to €0.33 from €0.21.
Net liquidity stood at €190.9 million as of 30 June 2026, down from €207.7 million at year-end 2025.
Aggregate investments in intangible assets and property, plant, and equipment totaled €49.8 million, up from €35.1 million in the prior year period.
Outlook and guidance
Full-year 2026 revenue is expected at €1.7 billion (±5%), with EBITDA forecasted between €110 million and €125 million.
Management anticipates moderate growth in case numbers and cost weights, but highlights significant uncertainties due to ongoing legislative changes, global crises, and regulatory impacts on remuneration.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Rhoen Klinikum
- Q1 2026 saw strong revenue and profit growth amid sector reforms and economic challenges.RHK
Q1 2026 - Revenue up 6.8% to €1.7bn, profit down, strong equity, €0.20 dividend proposed.RHKH2 2025
- Revenue up 7.8% year-over-year, but profit and margins declined amid sector reforms.RHKQ3 2025
- Revenue up 7.5% but profit down 28.6% as sector faces cost and regulatory headwinds.RHKH1 2025
- Revenue and profit rose strongly, but sector reforms and cost pressures shape the outlook.RHKQ3 2024
- Profit up 68.9% in H1 2024 on 6.5% revenue growth, with robust cash and strong outlook.RHKH1 2024
- 2024 saw RHÖN-KLINIKUM AG achieve record revenue, profit, and sector-leading performance.RHKH2 2024
- Revenue up, profit down as sector reforms and cost pressures reshape performance.RHKQ1 2025
Next Rhoen Klinikum earnings date
Q3 20265 Nov, 2026
Rhoen Klinikum
Next Rhoen Klinikum earnings date
Q3 20265 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Rhön-Klinikum AG is a German healthcare company that owns and operates hospitals and medical facilities, providing a wide range of inpatient and outpatient healthcare services. The company focuses on offering high-quality medical care across various specialties, including surgery, internal medicine, cardiology, and oncology. Rhön-Klinikum serves patients in Germany through its network of hospitals and clinics, leveraging advanced medical technology and a multidisciplinary approach to patient care. The company is headquartered in Bad Neustadt an der Saale, Germany, and its shares are listed on the Frankfurt Stock Exchange.